Carregant...
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Although current anticancer immunotherapies using immune checkpoint inhibitors (ICIs) have been reported with a high clinical success rate, numerous patients still bear ‘cold’ tumors with insufficient T cell infiltration and low immunogenicity, responding poorly to ICI therapy. Considering the advan...
Guardat en:
| Publicat a: | Nanomicro Lett |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Nature Singapore
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006526/ https://ncbi.nlm.nih.gov/pubmed/34138315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40820-021-00622-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|